Dashboard
1
Poor Management Efficiency with a low ROCE of 6.64%
- The company has been able to generate a Return on Capital Employed (avg) of 6.64% signifying low profitability per unit of total capital (equity and debt)
2
Poor long term growth as Net Sales has grown by an annual rate of -1.07% and Operating profit at -166.78% over the last 5 years
3
The company has declared Negative results for the last 4 consecutive quarters
4
With ROE of 0.68%, it has a expensive valuation with a 1.93 Price to Book Value
5
Market Beating Performance
Stock DNA
Pharmaceuticals & Biotechnology
CNY 17,377 Million (Large Cap)
283.00
NA
0.19%
-0.25
1.63%
3.18
Revenue and Profits:
Net Sales:
346 Million
(Quarterly Results - Mar 2026)
Net Profit:
82 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-3.17%
0%
-3.17%
6 Months
42.01%
0%
42.01%
1 Year
116.43%
0%
116.43%
2 Years
57.85%
0%
57.85%
3 Years
35.1%
0%
35.1%
4 Years
84.54%
0%
84.54%
5 Years
-26.68%
0%
-26.68%
Jinyu Bio-Technology Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
-1.07%
EBIT Growth (5y)
-166.78%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.19
Sales to Capital Employed (avg)
0.26
Tax Ratio
20.41%
Dividend Payout Ratio
30.24%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
6.64%
ROE (avg)
5.21%
Valuation key factors
Factor
Value
P/E Ratio
283
Industry P/E
Price to Book Value
1.93
EV to EBIT
-114.93
EV to EBITDA
57.81
EV to Capital Employed
2.11
EV to Sales
7.68
PEG Ratio
NA
Dividend Yield
0.32%
ROCE (Latest)
-1.84%
ROE (Latest)
0.68%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
Mildly Bullish
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY
Mar'26
Mar'25
Change(%)
Net Sales
346.50
348.80
-0.66%
Operating Profit (PBDIT) excl Other Income
65.90
123.40
-46.60%
Interest
0.00
0.40
-100.00%
Exceptional Items
-1.30
-0.10
-1,200.00%
Consolidate Net Profit
81.70
77.20
5.83%
Operating Profit Margin (Excl OI)
190.10%
168.40%
2.17%
USD in Million.
Net Sales
YoY Growth in quarter ended Mar 2026 is -0.66% vs 0.26% in Mar 2025
Consolidated Net Profit
YoY Growth in quarter ended Mar 2026 is 5.83% vs -27.51% in Mar 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
1,392.10
1,233.60
12.85%
Operating Profit (PBDIT) excl Other Income
258.30
251.30
2.79%
Interest
0.70
5.70
-87.72%
Exceptional Items
-5.50
-10.00
45.00%
Consolidate Net Profit
95.50
104.20
-8.35%
Operating Profit Margin (Excl OI)
1.10%
29.70%
-2.86%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 12.85% vs -22.50% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is -8.35% vs -62.40% in Dec 2024
About Jinyu Bio-Technology Co., Ltd. 
Jinyu Bio-Technology Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






